We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.4% more ownership

Funds ownership: 31.43% → 32.83% (+1.4%)

3% more capital invested

Capital invested by funds: $156M → $161M (+$5.16M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 120 → 115 (-5)

13% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 32

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
28
Reduced
32
Closed
14
Calls
$292K
Puts
–
Net Calls
+$292K
Net Calls Change
-$140K

Top Buyers

Rank Fund Capital Flow
1
MIM
Miller Investment Management
Pennsylvania
+$16.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.72M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$1.08M
4
Bank of America
Bank of America
North Carolina
+$1M
5
Citadel Advisors
Citadel Advisors
Florida
+$994K

Top Sellers

Rank Fund Capital Flow
1
KAS
Kestra Advisory Services
Texas
-$2.58M
2
LJAC
L.J. Altfest & Co
New York
-$2.28M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.08M
4
TAM
Tocqueville Asset Management
New York
-$1.97M
5
BIM
Bullseye Investment Management
Ohio
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
AL
26
Aspiriant LLC
California
$1.23M – – –
Stifel Financial
27
Stifel Financial
Missouri
$1.2M -$895K -5,529 -43%
LJAC
28
L.J. Altfest & Co
New York
$1.15M -$2.28M -14,121 -67%
Ameriprise
29
Ameriprise
Minnesota
$1.06M -$345K -2,133 -25%
Janney Montgomery Scott
30
Janney Montgomery Scott
Pennsylvania
$1.02M -$38K -235 -4%
Citadel Advisors
31
Citadel Advisors
Florida
$996K +$994K +6,145 New
Cerity Partners
32
Cerity Partners
New York
$932K +$930K +5,751 New
ACA
33
Atlas Capital Advisors
Wyoming
$924K – – –
CAN
34
Cetera Advisor Networks
California
$840K +$34.9K +216 +4%
SBH
35
Segall Bryant & Hamill
Illinois
$825K -$162K -1,000 -16%
JMPWA
36
JP Morgan Private Wealth Advisors
California
$799K -$1.2M -7,440 -60%
MML Investors Services
37
MML Investors Services
Massachusetts
$743K +$32.2K +199 +5%
Cambridge Investment Research Advisors
38
Cambridge Investment Research Advisors
Iowa
$680K -$1.11M -6,843 -62%
TRCT
39
Tower Research Capital (TRC)
New York
$657K +$182K +1,125 +38%
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$648K – – –
QPBE
41
Quintet Private Bank (Europe)
Luxembourg
$648K +$648K +4,004 New
NWA
42
Navis Wealth Advisors
New York
$637K – – –
PWP
43
Pursue Wealth Partners
California
$527K -$40.4K -250 -7%
TC
44
Telemus Capital
Michigan
$511K -$4.37K -27 -0.8%
CS
45
Comerica Securities
Michigan
$508K +$225K +1,389 +79%
GFG
46
Greystone Financial Group
Michigan
$469K +$468K +2,895 New
OC
47
Oppenheimer & Co
New York
$440K +$4.85K +30 +1%
BFC
48
Blue Fin Capital
Rhode Island
$434K – – –
WJWM
49
Williams Jones Wealth Management
New York
$431K – – –
Truist Financial
50
Truist Financial
North Carolina
$426K – – –
1
2
3 4 5

BBH Hedge Fund Activity: Q1 2023 in Review

115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2023, worth a combined $161M — up 3.3% from $156M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of BBH and 12 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 28 added.

The largest buyer was Miller Investment Management, adding an estimated $16.3M. The largest seller was Kestra Advisory Services, cutting an estimated $2.58M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2023, down from 120 in Q4 2022.
  • Funds reported $161M of VanEck Biotech ETF stock for Q1 2023, up 3.3% quarter-over-quarter.
  • 12 funds opened new VanEck Biotech ETF positions in Q1 2023 and 14 closed out, a net change of -2 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2023 was Miller Investment Management, an estimated $16.3M added.
  • The largest VanEck Biotech ETF seller in Q1 2023 was Kestra Advisory Services, an estimated $2.58M sold.

Based on aggregated 13F filings for Q1 2023.